[ Price : $8.95]
Researchers say studies have not proven a positive impact of drug company information on prescribing quality.[ Price : $8.95]
A bnet online column says that medical device company executives may find that a free speech defense in off-label marketing cases ...[ Price : $8.95]
FDA clears a Neurowave Medical Technologies 510(k) for Reletex, a transdermal neuromodulation device for alleviating nausea when u...[ Price : $8.95]
FDA approves Genentech's Herceptin (trastuzumab) in combination with chemotherapy for treating HER2-positive metastatic cancer of...[ Price : $8.95]
CDRH senior advisor Jay Crowley cautions that Unique Device Identifiers are certain to be a major regulatory concern in the future...[ Price : $8.95]
CDRH says medical device manufacturers should integrate risk management concepts throughout all aspects of their quality systems, ...[ Price : $8.95]
FDA clears PintPointe USAs PinPointe FootLaser for treating nail fungus.[ Price : $8.95]
FDA commissioner Margaret Hamburg seeks to reassure medical device manufacturers on impending changes to the 510(k) process, promi...